LUGANO topline data on track for mid-2026, with LUCIA readout to follow shortly after – – Continued favorable safety profile ...

A new study published in the Journal of the American Medical Association found that administration of anti–vascular ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Aflibercept 8 mg improved injection intervals in eyes ...

Background The standard of care for neovascular age-related macular degeneration (nAMD) is repeated intravitreal injection ...

Ashvattha Therapeutics ("Ashvattha"), a clinical-stage company developing a nanomedicine therapeutic that traverses the blood-retinal barrier in areas of inflammation selectively targeting activated ...

Biogen Inc. (Nasdaq: BIIB) today announced the successful completion of the acquisition of Apellis Pharmaceuticals, Inc.

VLTR-559 demonstrates sustained anti-VEGF activity and favorable safety at target clinical dosefor treatment of wetage-related macular degeneration ...

Resolution occurred after stopping dulaglutide, no obvious clues to mechanism ...

Two complement inhibitors tied to increased risk of wet AMD, but data called suspect ...

Australia prides itself on fairness. On looking after one another. But each year, when a federal budget is handed down, I find myself asking a simple question: who are we forgetting?

According to MingMed Biotechnology, 1 the QA102-CS201 trial enrolled 150 patients with intermediate atrophic AMD and randomly ...

Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today that it will showcase key real-world, product and pipeline data from its ophthalmology portfolio at the Association ...